newsfilter
← Latest News
PR Newswire·

Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective...